Current Prices from MoonLake Immunotherapeutics - Class A Ordinary Shares

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	MLTX	USD	09.06.2025 20:00	46,62 USD	46,88 USD -0,55 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	-4,27 %	21,19 %	22,57 %	-11,64 %	11,88 %	344,42 %

Company Profile for MoonLake Immunotherapeutics - Class A Ordinary Shares Share

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.

Company Data

Name MoonLake Immunotherapeutics - Class A Ordinary Shares

Company MoonLake Immunotherapeutics

Symbol MLTX

Website https://www.moonlaketx.com

Primary Exchange

NASDAQ

ISIN KY61559X1045

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Dr. Jorge Santos da Silva Ph.D.

Market Capitalization 2 Mrd.

Country Switzerland

Currency USD

Employees 0,1 T

Address Dorfstrasse 29, 6300 Zug

IPO Date 2020-10-20

ID Changes

Date	From	To
06.04.2022	HLXA	MLTX

Ticker Symbols

Name	Symbol
NASDAQ	MLTX

More Shares

Investors who MoonLake Immunotherapeutics - Class A Ordinary Shares hold also have the following shares in their portfolio:

TOTALENERG. 22/UND.FLRMTN Bond

WESTPAC BANKING CORPORATION CALL ZERO CPN INSTR 10/12/42 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog